| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Second Department of Surgery, Fukui Medical School, Fukui 910-11, Japan
Neovascularization promotes tumor growth by facilitating nutrient exchange and by the paracrine effect. To investigate the relationship between tumor angiogenesis and patient outcome in colorectal cancer, 133 primary tumors were immunostained for CD34 antigen. Blood vessels within five microscopic fields at x200 were counted, and the mean was assigned. Mean patient age was 62.9 years, mean follow-up was 56.4 months, and mean vessel count was 112 (range, 23298). Cox proportional hazards model and multivariate logistic regression analyses showed that the vessel count was the most important prognostic factor and correlated significantly with hematogenous, but not peritoneal or lymph node, metastasis.
1 To whom requests for reprints should be addressed, at The Second Department of Surgery, Fukui Medical School, Matsuoka-Cho, Yoshida-Gun, Fukui Prefecture 910-11, Japan. Phone: 81 776 61 3111, ext. 2347; Fax: 81 776 61 8114; E-mail: nobu@fmsrsa.fukui-med.ac.jp.
Received 10/21/96. Accepted 1/20/97.
This article has been cited by other articles:
![]() |
Y. Yao, Y. Pan, J. Chen, X. Sun, Y. Qiu, and Y. Ding Endoglin (CD105) Expression in Angiogenesis of Primary Hepatocellular Carcinomas: Analysis using Tissue Microarrays and Comparisons with CD34 and VEGF Ann. Clin. Lab. Sci., January 1, 2007; 37(1): 39 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Tien, K.-J. Chang, Y.-F. Chiu, K.-W. Huang, and P.-H. Lee Comparison of Angiogenic Factor Levels in Tumor Drainage and Peripheral Venous Blood From Colorectal Cancer Patients Ann. Surg. Oncol., November 1, 2006; 13(11): 1357 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lloyd, C. M. McIver, S.-A. Stephenson, P. J. Hewett, N. Rieger, and J. E. Hardingham Identification of Early-Stage Colorectal Cancer Patients at Risk of Relapse Post-Resection by Immunobead Reverse Transcription-PCR Analysis of Peritoneal Lavage Fluid for Malignant Cells Clin. Cancer Res., January 15, 2006; 12(2): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Koukourakis, A. Giatromanolaki, E. Sivridis, K. C. Gatter, A. L. Harris, and for Tumour and Angiogenesis Research Group Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer Clin. Cancer Res., December 15, 2005; 11(24): 8653 - 8660. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Szoke, K. Kayser, J.-D. Baumhakel, I. Trojan, J. Furak, L. Tiszlavicz, J. Eller, and K. Boda Prognostic significance of microvascularization in cases of operated lung cancer Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1106 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshimura, D. K. Dhar, H. Kohno, H. Kubota, T. Fujii, S. Ueda, S. Kinugasa, M. Tachibana, and N. Nagasue Prognostic Impact of Hypoxia-Inducible Factors 1{alpha} and 2{alpha} in Colorectal Cancer Patients: Correlation with Tumor Angiogenesis and Cyclooxygenase-2 Expression Clin. Cancer Res., December 15, 2004; 10(24): 8554 - 8560. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zaniboni and R. Labianca Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann. Onc., September 1, 2004; 15(9): 1310 - 1318. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rossler, T. Dietrich, H. Pavlakovic, L. Schweigerer, W. Havers, A. Schuler, N. Bornfeld, and H. Schilling Higher Vessel Densities in Retinoblastoma with Local Invasive Growth and Metastasis Am. J. Pathol., February 1, 2004; 164(2): 391 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Graziano and S. Cascinu Prognostic molecular markers for planning adjuvant chemotherapy trials in Dukes' B colorectal cancer patients: how much evidence is enough? Ann. Onc., July 1, 2003; 14(7): 1026 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cianchi, C. Cortesini, O. Fantappie, L. Messerini, N. Schiavone, A. Vannacci, S. Nistri, I. Sardi, G. Baroni, C. Marzocca, et al. Inducible Nitric Oxide Synthase Expression in Human Colorectal Cancer: Correlation with Tumor Angiogenesis Am. J. Pathol., March 1, 2003; 162(3): 793 - 801. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kabbinavar, H. I. Hurwitz, L. Fehrenbacher, N. J. Meropol, W. F. Novotny, G. Lieberman, S. Griffing, and E. Bergsland Phase II, Randomized Trial Comparing Bevacizumab Plus Fluorouracil (FU)/Leucovorin (LV) With FU/LV Alone in Patients With Metastatic Colorectal Cancer J. Clin. Oncol., January 1, 2003; 21(1): 60 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
E S Bamberger and C W Perrett Angiogenesis in epithelian ovarian cancer Mol. Pathol., December 1, 2002; 55(6): 348 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Giatromanolaki, E. Sivridis, G. Minopoulos, A. Polychronidis, C. Manolas, C. Simopoulos, and M. I. Koukourakis Differential Assessment of Vascular Survival Ability and Tumor Angiogenic Activity in Colorectal Cancer Clin. Cancer Res., May 1, 2002; 8(5): 1185 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cianchi, A. Palomba, L. Messerini, V. Boddi, G. Asirelli, G. Perigli, P. Bechi, A. Taddei, F. Pucciani, and C. Cortesini Tumor Angiogenesis in Lymph Node-Negative Rectal Cancer: Correlation With Clinicopathological Parameters and Prognosis Ann. Surg. Oncol., January 1, 2002; 9(1): 20 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-W. Tien, K.-J. Chang, Y.-M. Jeng, P.-H. Lee, M.-S. Wu, J.-T. Lin, and S.-M. Hsu Tumor Angiogenesis and Its Possible Role in Intravasation of Colorectal Epithelial Cells Clin. Cancer Res., June 1, 2001; 7(6): 1627 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Musso, M. Rehn, N. Théret, B. Turlin, P. Bioulac-Sage, D. Lotrian, J.-P. Campion, T. Pihlajaniemi, and B. Clément Tumor Progression Is Associated with a Significant Decrease in the Expression of the Endostatin Precursor Collagen XVIII in Human Hepatocellular Carcinomas Cancer Res., January 1, 2001; 61(1): 45 - 49. [Abstract] [Full Text] |
||||
![]() |
R. Masunaga, H. Kohno, D. K. Dhar, S. Ohno, M. Shibakita, S. Kinugasa, H. Yoshimura, M. Tachibana, H. Kubota, and N. Nagasue Cyclooxygenase-2 Expression Correlates with Tumor Neovascularization and Prognosis in Human Colorectal Carcinoma Patients Clin. Cancer Res., October 1, 2000; 6(10): 4064 - 4068. [Abstract] [Full Text] |
||||
![]() |
B. van Triest, H. M. Pinedo, J. L. G. Blaauwgeers, P. J. van Diest, P. S. Schoenmakers, D. A. Voorn, K. Smid, K. Hoekman, H. F. W. Hoitsma, and G. J. Peters Prognostic Role of Thymidylate Synthase, Thymidine Phosphorylase/ Platelet-derived Endothelial Cell Growth Factor, and Proliferation Markers in Colorectal Cancer Clin. Cancer Res., March 1, 2000; 6(3): 1063 - 1072. [Abstract] [Full Text] |
||||
![]() |
R. Maekawa, H. Maki, H. Yoshida, K. Hojo, H. Tanaka, T. Wada, N. Uchida, Y. Takeda, H. Kasai, H. Okamoto, et al. Correlation of Antiangiogenic and Antitumor Efficacy of N-biphenyl Sulfonyl-phenylalanine Hydroxiamic Acid (BPHA), an Orally-active, Selective Matrix Metalloproteinase Inhibitor Cancer Res., March 1, 1999; 59(6): 1231 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aotake, C.-D. Lu, Y. Chiba, R. Muraok, and N. Tanigawa Changes of Angiogenesis and Tumor Cell Apoptosis during Colorectal Carcinogenesis Clin. Cancer Res., January 1, 1999; 5(1): 135 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsuyama, Y. Chiba, M. Sasaki, H. Tanaka, R. Muraoka, and N. Tanigawa Tumor Angiogenesis as a Prognostic Marker in Operable Non-Small Cell Lung Cancer Ann. Thorac. Surg., May 1, 1998; 65(5): 1405 - 1409. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |